Globeflex Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Hold |
1,906
| – | – | 0.01% | 370 |
|
|
2025
Q1 | $135K | Buy |
+1,906
| New | +$135K | 0.01% | 349 |
|
|
2022
Q4 | – | Sell |
-1,164
| Closed | -$99K | – | 482 |
|
|
2022
Q3 | $99K | Buy |
+1,164
| New | +$99K | 0.02% | 398 |
|
|
2022
Q2 | – | Sell |
-1,462
| Closed | -$113K | – | 486 |
|
|
2022
Q1 | $113K | Buy |
+1,462
| New | +$113K | 0.02% | 393 |
|
|
2015
Q3 | – | Sell |
-4,200
| Closed | -$574K | – | 503 |
|
|
2015
Q2 | $574K | Hold |
4,200
| – | – | 0.11% | 294 |
|
|
2015
Q1 | $523K | Sell |
4,200
-7,840
| -65% | -$976K | 0.1% | 286 |
|
|
2014
Q4 | $1.09M | Sell |
12,040
-25,900
| -68% | -$2.34M | 0.21% | 201 |
|
|
2014
Q3 | $2.74M | Buy |
37,940
+34,140
| +898% | +$2.46M | 0.31% | 114 |
|
|
2014
Q2 | $236K | Buy |
+3,800
| New | +$236K | 0.03% | 342 |
|